Diaceutics PLC (AIM: DXRX)

Diaceutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	106	73	64	86	112	71
Market Cap Growth	15.14%	15.14%	-25.74%	-23.60%	58.13%	-
Enterprise Value	90	57	45	62	83	57
Last Close Price	1.25	0.87	0.76	1.02	1.33	1.02
PE Ratio	-	-41.97	89.88	154.57	393.57	164.52
PS Ratio	4.44	3.09	3.26	6.15	8.84	5.28
PB Ratio	2.58	1.80	1.50	2.11	2.79	3.53
P/FCF Ratio	88.99	61.82	12.97	17150.06	967.52	-97.36
P/OCF Ratio	55.93	55.93	12.50	150.44	443.60	-112.66
EV/Sales Ratio	3.80	2.39	2.29	4.46	6.50	4.25
EV/EBITDA Ratio	555.87	555.87	21.53	40.96	194.30	24.93
EV/EBIT Ratio	-18.79	-18.79	77.74	112.96	-305.85	27.35
EV/FCF Ratio	75.95	47.81	9.10	12425.86	711.89	-78.34
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.00	0.01
Debt / EBITDA Ratio	4.73	4.73	0.60	1.00	0.28	0.05
Debt / FCF Ratio	1.02	1.02	0.27	312.20	1.02	-0.15
Asset Turnover	0.50	0.50	0.42	0.31	0.39	0.89
Quick Ratio	6.11	6.11	8.07	11.24	11.33	8.08
Current Ratio	6.40	6.40	8.23	11.41	11.53	8.23
Return on Equity (ROE)	-4.19%	-4.19%	1.74%	1.39%	0.87%	3.50%
Return on Assets (ROA)	-3.99%	-3.99%	0.77%	0.78%	-0.51%	8.65%
Return on Capital (ROIC)	-4.40%	-4.40%	0.84%	0.83%	-0.56%	9.81%
Earnings Yield	-1.66%	-2.38%	1.14%	0.65%	0.23%	0.56%
FCF Yield	1.12%	1.62%	7.71%	0.01%	0.10%	-1.03%
Buyback Yield / Dilution	2.16%	2.16%	-1.35%	-9.14%	-21.29%	-42.92%
Total Shareholder Return	2.16%	2.16%	-1.35%	-9.14%	-21.29%	-42.92%

Source: S&P Capital IQ. Standard template. Financial Sources.